Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 02 Dec 2021

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

in Hematologic Malignancies

Ajay Gogia
Sukesh Nair
Shalabh Arora
Lalit Kumar
Atul Sharma
Ritu Gupta
Ahitagni Biswas
Saumyaranjan Mallick

Frontiers in Oncology

doi 10.3389/fonc.2021.770747

4,010 views
9 citations

Original Research

Published on 01 Dec 2021

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E

in Hematologic Malignancies

Jack G. Fisher
Christopher J. Walker
Amber DP. Doyle
Peter WM. Johnson
Francesco Forconi
Mark S. Cragg
Yosef Landesman
Salim. I. Khakoo
Matthew D. Blunt

Frontiers in Oncology

doi 10.3389/fonc.2021.785635

8,079 views
21 citations

Original Research

Published on 01 Dec 2021

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Yongsheng Ruan
Hye Na Kim
Heather A. Ogana
Zesheng Wan
Samantha Hurwitz
Cydney Nichols
Nour Abdel-Azim
Ariana Coba
Seyoung Seo
Yong-Hwee Eddie Loh

Frontiers in Oncology

doi 10.3389/fonc.2021.766888

5,422 views
2 citations

Review

Published on 29 Nov 2021

Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies

in Hematologic Malignancies

Chun-fung Sin
Pui-hei Marcus Man

Frontiers in Oncology

doi 10.3389/fonc.2021.750789

50,472 views
53 citations

Mini Review

Published on 29 Nov 2021

Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

in Hematologic Malignancies

Thomas Chatzikonstantinou
Christos Demosthenous
Panagiotis Baliakas

Frontiers in Oncology

doi 10.3389/fonc.2021.788761

4,926 views
9 citations

Mini Review

Published on 26 Nov 2021

Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability

in Hematologic Malignancies

Kristyna Zavacka
Karla Plevova

Frontiers in Oncology

doi 10.3389/fonc.2021.771664

5,261 views
10 citations

Brief Research Report

Published on 25 Nov 2021

An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera

in Hematologic Malignancies

Monica Barone
Martina Barone
Francesca Ricci
Giuseppe Auteri
Giulia Corradi
Francesco Fabbri
Valentina Papa
Erika Bandini
Giovanna Cenacchi
Pier Luigi Tazzari

Frontiers in Oncology

doi 10.3389/fonc.2021.715217

4,499 views
9 citations

Systematic Review

Published on 23 Nov 2021

Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis

in Hematologic Malignancies

Xinwen Zhang
Jialin Duan
Zhenyu Wen
Hao Xiong
Xiaomin Chen
Yang Liu
Kunyu Liao
Chunlan Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.766672

5,804 views
25 citations

Review

Published on 23 Nov 2021

Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas

in Hematologic Malignancies

Shenon Sethi
Zachary Epstein-Peterson
Anita Kumar
Caleb Ho

Frontiers in Oncology

doi 10.3389/fonc.2021.739441

10,621 views
12 citations

Mini Review

Published on 19 Nov 2021

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact

in Hematologic Malignancies

Till Braun
Annika Dechow
Gregor Friedrich
Michael Seifert
Johanna Stachelscheid
Marco Herling

Frontiers in Oncology

doi 10.3389/fonc.2021.775363

7,577 views
17 citations

Review

Published on 17 Nov 2021

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

in Hematologic Malignancies

Panagiotis T. Diamantopoulos
Nora-Athina Viniou

Frontiers in Oncology

doi 10.3389/fonc.2021.722507

10,700 views
4 citations

Original Research

Published on 17 Nov 2021

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission

in Hematologic Malignancies

Yiyun Wang
Linqin Wang
Yifan Zeng
Ruimin Hong
Cheng Zu
Elaine Tan Su Yin
Houli Zhao
Guoqing Wei
Li Yang
Aiyun Jin

Frontiers in Oncology

doi 10.3389/fonc.2021.755584

5,960 views
11 citations

Original Research

Published on 16 Nov 2021

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

in Hematologic Malignancies

Hong-Hu Zhu
Ya-Fang Ma
Kang Yu
Gui-Fang Ouyang
Wen-Da Luo
Ren-Zhi Pei
Wei-Qun Xu
Hui-Xian Hu
Shu-Ping Mo
Xiao-Hua Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.762653

9,537 views
23 citations

Review

Published on 16 Nov 2021

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

in Hematologic Malignancies

Andrea Kuendgen
Annika Kasprzak
Ulrich Germing

Frontiers in Oncology

doi 10.3389/fonc.2021.778741

7,839 views
8 citations

Original Research

Published on 12 Nov 2021

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia

in Hematologic Malignancies

Mingyue Shi
Junwei Niu
Xiaona Niu
Honggang Guo
Yanliang Bai
Jie Shi
Weiya Li
Kai Sun
Yuqing Chen
Fengmin Shao

Frontiers in Oncology

doi 10.3389/fonc.2021.763232

4,355 views
14 citations

Review

Published on 11 Nov 2021

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

in Hematologic Malignancies

Chrysi Galigalidou
Laura Zaragoza-Infante
Anastasia Iatrou
Anastasia Chatzidimitriou
Kostas Stamatopoulos
Andreas Agathangelidis

Frontiers in Oncology

doi 10.3389/fonc.2021.769612

33,552 views
19 citations

Review

Published on 11 Nov 2021

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

in Hematologic Malignancies

Diletta Fontana
Carlo Gambacorti-Passerini
Rocco Piazza

Frontiers in Oncology

doi 10.3389/fonc.2021.756348

8,472 views
9 citations

Review

Published on 10 Nov 2021

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma

in Hematologic Malignancies

Fatih M. Uckun

Frontiers in Oncology

doi 10.3389/fonc.2021.760382

6,982 views
14 citations

Review

Published on 10 Nov 2021

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies

in Hematologic Malignancies

Mojdeh Soltani
Yue Zhao
Zhijia Xia
Mazdak Ganjalikhani Hakemi
Alexandr V. Bazhin

Frontiers in Oncology

doi 10.3389/fonc.2021.767026

13,427 views
57 citations

Original Research

Published on 09 Nov 2021

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data

in Hematologic Malignancies

Akanksha Farswan
Anubha Gupta
Krishnamachari Sriram
Atul Sharma
Lalit Kumar
Ritu Gupta

Frontiers in Oncology

doi 10.3389/fonc.2021.720932

4,418 views
12 citations

Perspective

Published on 08 Nov 2021

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

in Hematologic Malignancies

Susan M. O’Brien
Jennifer R. Brown
John C. Byrd
Richard R. Furman
Paolo Ghia
Jeff P. Sharman
William G. Wierda

Frontiers in Oncology

doi 10.3389/fonc.2021.720704

28,762 views
59 citations

Case Report

Published on 08 Nov 2021

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

in Hematologic Malignancies

Chao Chen
Wei Zhang
Daobin Zhou
Yan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.757403

3,387 views
9 citations

Mini Review

Published on 05 Nov 2021

Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications

in Hematologic Malignancies

John M. Astle
Huiya Huang

Frontiers in Oncology

doi 10.3389/fonc.2021.704464

5,837 views
11 citations

Original Research

Published on 05 Nov 2021

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities

in Hematologic Malignancies

Carmen-Mariana Aanei
Richard Veyrat-Masson
Cristina Selicean
Mirela Marian
Lauren Rigollet
Adrian Pavel Trifa
Ciprian Tomuleasa
Adrian Serban
Mohamad Cherry
Pascale Flandrin-Gresta

Frontiers in Oncology

doi 10.3389/fonc.2021.746951

7,318 views
7 citations

2,059 articles

articles

Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E

Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia

Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies

Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype

Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability

An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera

Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis

Current Knowledge in Genetics, Molecular Diagnostic Tools, and Treatments for Mantle Cell Lymphomas

Advanced Pathogenetic Concepts in T-Cell Prolymphocytic Leukemia and Their Translational Impact

Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission

Early Death and Survival of Patients With Acute Promyelocytic Leukemia in ATRA Plus Arsenic Era: A Population-Based Study

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia

Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia

Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple Myeloma

The Importance of Cellular Metabolic Pathways in Pathogenesis and Selective Treatments of Hematological Malignancies

Does Ethnicity Matter in Multiple Myeloma Risk Prediction in the Era of Genomics and Novel Agents? Evidence From Real-World Data

Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review

Mass Cytometry in Hematologic Malignancies: Research Highlights and Potential Clinical Applications

Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities